Try our Advanced Search for more refined results
Your firm must have an account to access this feature
Track this case
1:15-cv-01025
Delaware
Patent
Richard G. Andrews
Novartis Pharmaceuticals Corp. and Amneal Pharmaceuticals Inc. have settled a suit accusing generic drugmaker Amneal of infringing two patents when applying to sell its own version of the dementia-treatment patch, Exelon, according to an order signed Wednesday in Delaware federal court.
Novartis Pharmaceuticals Corp. and the co-owner of some of its patents filed a pair of suits in Delaware federal court Thursday over generic-drug makers Dr. Reddy's Laboratories Ltd. and Amneal Pharmaceuticals Inc.'s plans to make and market generic versions of Novartis' Exelon patch used to treat dementia associated with Parkinson's or Alzheimer's disease.